Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds | Health

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds | Health

Patients taking Wegovy have practically five times the risk of sudden sight loss of these on Ozempic, a large-scale study you have discovered. Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medicines equivalent to semaglutide (offered as Wegovy, Ozempic and Rybelsus) and tirzepetide (offered as Mounjaro) assist cut back blood sugar ranges, sluggish digestion and cut back…

Read Full News